Therapeutic Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection

• Hoofdauteurs: Yaeni Kim (Auteur), Yu Ah Hong (Auteur), Byung Ha Chung (Auteur), Bum Soon Choi (Auteur), Cheol Whee Park (Auteur), Yeong Jin Choi (Auteur), Yong-Soo Kim (Auteur), Chul Woo Yang (Auteur)
• Formaat: Boek
• Gepubliceerd in: The Korean Society of Nephrology, 2014-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

While combination therapy of Rituximab (RTX) and intravenous immunoglobulin (IVIg) (RIT) has been proposed as therapeutic strategy for the treatment of chronic active antibody-mediated rejection (CAMR), its efficacy has not been established. In this study, we compared clinical outcome between the tr...